摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-Deoxy-6-fluoroglucose | 62182-13-2

中文名称
——
中文别名
——
英文名称
6-Deoxy-6-fluoroglucose
英文别名
6-(fluoromethyl)oxane-2,3,4,5-tetrol
6-Deoxy-6-fluoroglucose化学式
CAS
62182-13-2
化学式
C6H11FO5
mdl
MFCD04037831
分子量
182.15
InChiKey
SHFYXYMHVMDNPY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.1
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    90.2
  • 氢给体数:
    4
  • 氢受体数:
    6

SDS

SDS:1f8b10f3b0f8c715b30bbe69bc351067
查看

文献信息

  • MONOSACCHARIDE-BASED COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE AND INFLAMMATORY DERMATOLOGICAL DISEASES
    申请人:Priebe Waldemar
    公开号:US20120276108A1
    公开(公告)日:2012-11-01
    The present invention relates to compounds and methods which may be useful as inhibitors of glycolysis, inhibitors of protein glycosylation, anti-virals, and down-regulators of insulin receptor and IGF-1 receptor for the treatment or prevention of inflammatory dermatological diseases or proliferative dermatological diseases.
  • [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING FAT METABOLISM<br/>[FR] COMPOSES, COMPOSITIONS ET METHODES PERMETTANT DE MODULER LE METABOLISME DES GRAISSES
    申请人:OBETHERAPY BIOTECHNOLOGY
    公开号:WO2004037159A2
    公开(公告)日:2004-05-06
    Methods, compositions and methods of identifying candidate compounds, for modulating fat metabolism and/or inhibiting Apobec-1 activity are provided.
  • [EN] MONOSACCHARIDE-BASED COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE AND INFLAMMATORY DERMATOLOGICAL DISEASES<br/>[FR] COMPOSÉS À BASE DE MONOSACCHARIDES POUR LE TRAITEMENT DE MALADIES DERMATOLOGIQUES PROLIFÉRATIVES ET INFLAMMATOIRES
    申请人:INTERTECH BIO LLC
    公开号:WO2012097052A2
    公开(公告)日:2012-07-19
    The present invention relates to compounds and methods which may be useful as inhibitors of glycolysis, inhibitors of protein glycosylation, anti-virals, and down-regulators of insulin receptor and IGF- 1 receptor for the treatment or prevention of inflammatory dermatological diseases or proliferative dermatological diseases.
查看更多